COMPANY PROFILE

Patented Rigenera® Technology features single-use devices called "Rigeneracons" for minimally invasive micrograft extraction procedure from skin, cartilage, and bone. The technology is optimized to preserve cell viability and it is used in aesthetic treatments, wound care, orthopaedics, and oral-maxillofacial surgery. Our headquarters is in Torino, Italy, with side offices in Barcelona, Dubai, Hong Kong, and Brazil. Rigenera® is CE and FMA certified, US FDA listed, and more certifications.